Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lode

Showing results (321-330 of 369) with videos related to

Pageof 37
Sort By:
Medizinische Monatsschrift Fur Pharmazeuten|April 1, 1992
[Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases]D Adam, R Ferlinz, R Frei, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 2000
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microfloraG Beyer, M Hiemer-Bau, S Ziege, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1995
[BiPAP therapy of respiratory disorders in patients with congenital neuromuscular diseases]H Müller-Pawlowski, A von Moers, M Raffenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1992
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989H F Geerdes, D Ziegler, H Lode, et al.
Deutsche Medizinische Wochenschrift (1946)|August 22, 1997
[Changes in the spectrum of the causative agents of community-acquired pneumonias (1982-1992)]M Allewelt, D Steinhoff, M Rahlwes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 15, 2004
Antiviral treatment and prophylaxis of influenza in primary care: German recommendationsP Wutzler, K-D Kossow, H Lode, et al.
Respiratory Medicine|October 17, 2003
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumoniaH Lode, C Grossman, S Choudhri, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial speciesH F Geerdes-Fenge, A Wiedersich, S Wagner, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intakeD Sassella, G Cassinelli, R Corigli, et al.
Annals of the New York Academy of Sciences|May 28, 1994
Cells and cytokines in chronic bronchial infectionJ Eller, J R Lapa e Silva, L W Poulter, et al.
Pageof 37

Showing results (321-330 of 369) with videos related to

Sort By:
Pageof 37
Medizinische Monatsschrift Fur Pharmazeuten|April 1, 1992
[Antibacterial therapy in infectious bronchial diseases. Recommendations of the German League for control of respiratory tract diseases]D Adam, R Ferlinz, R Frei, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 2000
Impact of moxifloxacin versus clarithromycin on normal oropharyngeal microfloraG Beyer, M Hiemer-Bau, S Ziege, et al.
Medizinische Klinik (Munich, Germany : 1983)|April 1, 1995
[BiPAP therapy of respiratory disorders in patients with congenital neuromuscular diseases]H Müller-Pawlowski, A von Moers, M Raffenberg, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 1992
Septicemia in 980 patients at a university hospital in Berlin: prospective studies during 4 selected years between 1979 and 1989H F Geerdes, D Ziegler, H Lode, et al.
Deutsche Medizinische Wochenschrift (1946)|August 22, 1997
[Changes in the spectrum of the causative agents of community-acquired pneumonias (1982-1992)]M Allewelt, D Steinhoff, M Rahlwes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 15, 2004
Antiviral treatment and prophylaxis of influenza in primary care: German recommendationsP Wutzler, K-D Kossow, H Lode, et al.
Respiratory Medicine|October 17, 2003
Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumoniaH Lode, C Grossman, S Choudhri, et al.
Antimicrobial Agents and Chemotherapy|November 18, 2000
Levofloxacin pharmacokinetics and serum bactericidal activities against five enterobacterial speciesH F Geerdes-Fenge, A Wiedersich, S Wagner, et al.
The Journal of Antimicrobial Chemotherapy|March 1, 1989
Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intakeD Sassella, G Cassinelli, R Corigli, et al.
Annals of the New York Academy of Sciences|May 28, 1994
Cells and cytokines in chronic bronchial infectionJ Eller, J R Lapa e Silva, L W Poulter, et al.
Pageof 37